FCHIP Extension Act
- Sponsor
- Sen. Hoeven, John [R-ND]
- Committees
- Finance Committee (primary)
- Last action
- Sep 23, 2026
Bottom line
This bill extends a federal demonstration project aimed at improving healthcare access and integration in designated frontier communities for an additional five years, totaling a decade.
What it actually does
This bill amends the Medicare Improvements for Patients and Providers Act of 2008 to extend the Frontier Community Health Integration Project Demonstration. Specifically, it changes the authorized duration of the demonstration project from a 5-year period to a 10-year period, effectively doubling its length.
Proponents argue
Supporters argue that extending the demonstration project provides crucial stability for healthcare providers in frontier communities, allowing more time to gather comprehensive data on the program's long-term effectiveness in improving health outcomes and reducing costs in these challenging, sparsely populated areas. They contend it ensures continued access to vital integrated health services for underserved populations.
Opponents contend
Critics might argue that extending a demonstration project without a thorough interim evaluation could lead to inefficient spending or perpetuate a program that may not be achieving its intended goals effectively. They may also raise concerns about the precedent of indefinitely extending 'demonstration' projects without rigorous re-evaluation, potentially diverting resources from other, more impactful initiatives.
The bill is exceptionally short and clear, making it very accessible for any reader to understand its provisions quickly.
Section 2(a)
Extension of Frontier Community Health Integration Project Demonstration
This provision amends subsection (f)(1) of section 123 of the Medicare Improvements for Patients and Providers Act of 2008. It strikes the existing '5-year period' language and inserts '10-year period,' thereby extending the authorized duration of the Frontier Community Health Integration Project Demonstration by an additional five years. The amendment is set to take effect on December 31, 2026.
Supporters argue
Supporters argue that the extension is vital for allowing the demonstration to fully mature and collect robust, long-term data on its impact on health outcomes and cost-effectiveness in unique frontier settings. They emphasize that this stability is essential for providers to plan and deliver consistent, high-quality care without interruption.
Critics contend
Opponents might contend that extending the demonstration without a comprehensive interim review risks perpetuating a program that may not be optimally effective or fiscally responsible. They could argue that a more rigorous evaluation should precede any extension to ensure that federal resources are being used in the most impactful way.
Tradeoffs
This provision balances the desire for program stability and the collection of long-term data necessary for a thorough evaluation against the need for regular oversight and accountability in federal spending, particularly for demonstration projects designed to test new models.